SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007850
Filing Date
2019-05-20
Accepted
2019-05-20 15:14:23
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 504037
2 ex10-59.htm EX-10.59 46163
3 ex10-60.htm EX-10.60 64056
4 ex31-1.htm EX-31.1 35961
5 ex32-1.htm EX-32.1 7857
  Complete submission text file 0001493152-19-007850.txt   3318102

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE imun-20190331.xml EX-101.INS 506675
7 XBRL SCHEMA FILE imun-20190331.xsd EX-101.SCH 49247
8 XBRL CALCULATION FILE imun-20190331_cal.xml EX-101.CAL 47716
9 XBRL DEFINITION FILE imun-20190331_def.xml EX-101.DEF 160313
10 XBRL LABEL FILE imun-20190331_lab.xml EX-101.LAB 284463
11 XBRL PRESENTATION FILE imun-20190331_pre.xml EX-101.PRE 232761
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 19838505
SIC: 2834 Pharmaceutical Preparations